A 68-Year-Old Man With Mantle Cell Lymphoma

Recommendations for treating a 68-year-old male with mantle cell lymphoma with a BTK inhibitor once he has relapsed on prior therapy.

EP. 1: Case Assessment: 68-Year-Old Patient With MCL

May 18th 2020

EP. 2: Diagnosing MCL and Making Informed Treatment Decisions

May 18th 2020

EP. 3: Initiating Therapy for Mantle Cell Lymphoma

May 18th 2020

EP. 4: Relapsed Mantle Cell Lymphoma Treatment Landscape

May 18th 2020

EP. 5: Administration of BTK Inhibitors for Mantle Cell Lymphoma

May 18th 2020

EP. 6: BTK Inhibitor Toxicities in Mantle Cell Lymphoma

May 18th 2020

EP. 7: BTK Inhibitors in MCL: Long-Term Safety & Efficacy Data

May 18th 2020

EP. 8: Next Steps in Relapsed/Refractory Mantle Cell Lymphoma

May 18th 2020

Advertisement

Advertisement